The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Qiagen, a molecular diagnostics company, and spinoff company APIS Assay Technologies, the AHSN, academia and the NHS have created a long-term partnership that has brought investment and jobs to the Greater Manchester area. Access to new tests and targeted treatments developed through pioneering research will bring fast-tracked real health benefits to local residents, and ultimately people nationally and internationally.
Gendius developed product Intellin® is an intelligent diabetes management platform that uses clinical data to predict the trajectory of an individual's diabetes and helps to mitigate progression through smart tips. Powered by sophisticated AI algorithms, Intellin® is changing the way diabetes is managed. The Intellin® App is today the fastest downloaded diabetes app in the world.
The PD Safe is designed to identify potentially fatal infection in dialysis patients. This Microbiosensor device is aimed at patients with kidney failure who are being treated using peritoneal dialysis therapy (PD) and acts as an early warning system for peritoneal infection.
An innovative cancer diagnostic device developed by Manchester-based Zilico helps to improve accuracy in detecting cervical disease.
Malinko’s Intelligent Service Management system has been co-designed and developed with community healthcare professionals to ‘free up time to care’ in NHS community services. It is a clinically safe and ‘intelligent’ scheduling system that uses artificial intelligence (AI) and clinical algorithms to optimally manage the delivery of patient care services.
Safe Steps are a health technology SME focussed on preventing falls for our ageing population. They do so by providing software solutions to health and social care organisations to conduct falls risk assessments and put in place personalised care plans to reduce the risk of falls.
